Synendos Therapeutics was selected among the three finalists at the perfect pitch competition held at the BioTrinity London conference for Europe’s Leading Biopartnering and Investment.
https://www.biotrinity.com/perfectpitch
Recent Posts
See AllSynendos is present at the Digital BIO-Europe Spring 2021 (March 22-25, 2021) and takes part in the first Virtual Swiss Biotech Pavilion.
Synendos Therapeutics selected as Switzerland Global Enterprise exhibitor at the Digital Bio 2020 (June 8-12 2020).
Synendos at International Cannabinoid-Based Drug Discovery and Development